[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100433041":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":36,"centralContacts":41,"locations":51,"responsibleParty":67,"collaborators":46,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":39,"acronym":46,"eligibilityCriteria":74,"healthyVolunteers":71,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":46,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":89,"whyStopped":46,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"group 1","EXPERIMENTAL","oral methylprednisolone, 40 mg for 3 days, 20 mg for 3 days, and 8 mg for 6 days",[13],"Drug: methylprednisolone",{"label":15,"type":10,"description":16,"interventionNames":17},"group 2","oral methylprednisolone, 20 mg for 3 days, 10 mg for 3 days, and 4 mg for 6 days",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"group 3","budesonide atomization suspension (AstraZeneca Trading Co., Ltd, AU.) inhaled through the nose atomized with an air compression atomizer for 4 weeks, 2 mg for the first 2 weeks and reduced to 1 mg for the last 2 weeks.",[22],"Drug: budesonide atomization suspension",[24,31],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DRUG","methylprednisolone","The patients were treated with three protocols: (1) oral methylprednisolone, 40 mg for 3 days, 20 mg for 3 days, and 8 mg for 6 days; (2) oral methylprednisolone, 20 mg for 3 days, 10 mg for 3 days, and 4 mg for 6 days. At the same time, all patients received olfactory training for 12 weeks as proposed by Hummel et al",[9,15],[30],"Olfactory training",{"type":25,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"budesonide atomization suspension","(3) budesonide atomization suspension (AstraZeneca Trading Co., Ltd, AU.) inhaled through the nose atomized with an air compression atomizer for 4 weeks, 2 mg for the first 2 weeks and reduced to 1 mg for the last 2 weeks. At the same time, all patients received olfactory training for 12 weeks as proposed by Hummel et al",[19],[30],[37],{"name":38,"affiliation":39,"role":40},"Ze-xing Chen, master","Second Affiliated Hospital, College of Medicine, Zhejiang University","PRINCIPAL_INVESTIGATOR",[42,48],{"name":43,"role":44,"phone":45,"phoneExt":46,"email":47},"Hong-Gang Duan, doctor","CONTACT","86(China)-571-87783774",null,"2314061@zju.edu.cn",{"name":49,"role":44,"phone":45,"phoneExt":46,"email":50},"Fang Ji, master","1506065@zju.edu.cn",[52],{"facility":53,"status":46,"city":54,"state":55,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Department of Otolaryngology, Second Affiliated Hospital, College of Medicine, Zhejiang University","Hangzhou","Zhejiang","310000","China","CN",{"type":60,"coordinates":61},"Point",[62,63],120.16142,30.29365,{"lat":63,"lon":62},[66],{"name":43,"role":44,"phone":45,"phoneExt":46,"email":47},{"type":68,"investigatorFullName":46,"investigatorTitle":46,"investigatorAffiliation":46,"oldNameTitle":46,"oldOrganization":46},"SPONSOR","100433041","phase-2-factors-influencing-the-prognosis-of-olfactory-dysfunction-after-upper-sensation-100433041",false,"NCT04918953","Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation","Inclusion Criteria:\n\n* The history of upper respiratory tract infection was confirmed, and the previous sense of smell was normal.\n\nExclusion Criteria:\n\n* Other causes of olfactory disorder suggested by the history","ALL","18 Years","70 Years",{"count":79,"type":80},90,"ESTIMATED","INTERVENTIONAL",[83],"PHASE2","Objective: This study aimed to analyze the outcomes of post-infectious olfactory dysfunction treated with different doses of corticosteroids and specify factors related to the curative effect. Methods: The medical records of patients diagnosed with post-infectious olfactory dysfunction from January 2020 to december 2025 were reviewed. All patients were treated with different doses of oral corticosteroids for 12 days or they inhaled corticosteroids for 1 month.",[86],"Outcome",[88],"Corticosteroid, olfactory dysfunction, Smell.","NOT_YET_RECRUITING","2021-06-08",{"date":92,"type":93},"2021-06-09","ACTUAL",{"date":95,"type":80},"2021-06-02",{"date":97,"type":80},"2026-12-30",{"name":5,"class":6},1]